Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$1.61B |
| 2 |
Progressive
PGR
|
+$1.49B |
| 3 |
CGHM
Capital Group Municipal High-Income ETF
CGHM
|
+$1.44B |
| 4 |
Accenture
ACN
|
+$1.3B |
| 5 |
Gartner
IT
|
+$910M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.58B |
| 2 |
GE Vernova
GEV
|
+$1.45B |
| 3 |
Broadcom
AVGO
|
+$1.45B |
| 4 |
VICI Properties
VICI
|
+$1.39B |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.8% |
| 2 | Industrials | 12.85% |
| 3 | Financials | 12.29% |
| 4 | Communication Services | 10.98% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Insmed
INSM
$28.9B
| $1.09B | 0.18% |
7,553,853
+74,994
| +1% | +$9.19M |
|
102
SAP
SAP
$236B
| $1.07B | 0.17% |
4,010,185
-47,904
| -1% | -$13.5M |
|
103
Blue Owl Capital
OWL
$19.1B
| $1.06B | 0.17% |
62,726,334
+2,141,873
| +4% | +$40.7M |
|
104
Mettler-Toledo International
MTD
$28.8B
| $1.06B | 0.17% |
859,559
+10,395
| +1% | +$13M |
|
105
S&P Global
SPGI
$121B
| $1.03B | 0.17% |
2,115,479
-493,955
| -19% | -$264M |
|
106
FedEx
FDX
$77.3B
| $1.02B | 0.16% |
4,310,402
-3,215,346
| -43% | -$741M |
|
107
Marriott International
MAR
$92.5B
| $999M | 0.16% |
3,835,281
-266,603
| -6% | -$71.6M |
|
108
Texas Instruments
TXN
$253B
| $984M | 0.16% |
5,358,516
-1,752,242
| -25% | -$343M |
|
|
NVO
109
Novo Nordisk
NVO
$203B
| $983M | 0.16% |
17,713,424
+6,092,192
| +52% | +$357M |
|
110
Chubb
CB
$132B
| $970M | 0.16% |
3,435,863
-2,753,299
| -44% | -$758M |
|
111
EQT Corp
EQT
$33.8B
| $964M | 0.16% |
17,703,481
-225,464
| -1% | -$11.9M |
|
112
Royalty Pharma
RPRX
$26.4B
| $960M | 0.16% |
27,212,694
+5,332,074
| +24% | +$193M |
|
113
Elevance Health
ELV
$86.6B
| $955M | 0.15% |
2,954,717
-3,533,312
| -54% | -$1.1B |
|
114
Aramark
ARMK
$15.9B
| $946M | 0.15% |
24,646,909
+580,215
| +2% | +$23.5M |
|
115
Canadian National Railway
CNI
$76.4B
| $946M | 0.15% |
10,035,944
-469,639
| -4% | -$45.3M |
|
116
Capital Group Dividend Value ETF
CGDV
$38.9B
| $946M | 0.15% |
22,501,357
-1,189,928
| -5% | -$48.9M |
|
117
East-West Bancorp
EWBC
$18.5B
| $936M | 0.15% |
8,788,772
-340,100
| -4% | -$35.8M |
|
118
Booking.com
BKNG
$159B
| $933M | 0.15% |
4,322,300
+19,050
| +0.4% | +$4.25M |
|
119
Procter & Gamble
PG
$335B
| $933M | 0.15% |
6,073,436
+53,506
| +0.9% | +$8.36M |
|
120
Sherwin-Williams
SHW
$87.4B
| $926M | 0.15% |
2,675,299
+52,322
| +2% | +$18.4M |
|
121
Watsco Inc
WSO
$12.8B
| $924M | 0.15% |
2,285,895
+2,014,233
| +741% | +$861M |
|
122
Brookfield Asset Management
BAM
$87.1B
| $916M | 0.15% |
16,082,874
-190,616
| -1% | -$11.3M |
|
123
Blackstone
BX
$110B
| $915M | 0.15% |
5,354,683
-4,004,831
| -43% | -$686M |
|
|
WCN
124
Waste Connections
WCN
$41.6B
| $887M | 0.14% |
5,047,338
-958,474
| -16% | -$174M |
|
125
Dollar Tree
DLTR
$24.7B
| $874M | 0.14% |
9,264,163
-268,170
| -3% | -$28.7M |
|
Similar funds
Capital International Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital International Investors held 472 positions worth $619B, up 6.7% from $581B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Capital International Investors's Q3 2025 filing shows 29 new, 218 increased, 160 reduced and 24 closed positions. Its largest new stake was Gartner: 3,119,843 shares worth $820M. The largest sale was Bristol-Myers Squibb, an estimated $1.58B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- Capital International Investors's largest Q3 2025 buy was Gartner: 3,119,843 shares worth $820M.
- Capital International Investors added most to Amphenol in Q3 2025, an estimated $1.61B increase.
- Capital International Investors's biggest Q3 2025 reduction was Bristol-Myers Squibb, cutting an estimated $1.58B.
- Capital International Investors fully exited Eaton in Q3 2025, selling an estimated $607M.
- Capital International Investors's ten largest holdings make up 35% of its $619B portfolio in Q3 2025.
- Capital International Investors opened 29 new positions and closed 24 in Q3 2025.
- Capital International Investors's portfolio value rose 6.7% quarter-over-quarter to $619B.
Based on Capital International Investors's 13F filing for Q3 2025, filed 13 Nov 2025.